NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.56	22.07	17.27	11.66	22.45	16.93
Cash & Short-Term Investments	16.56	22.07	17.27	11.66	22.45	16.93
Cash Growth	14.43%	27.81%	48.10%	-48.07%	32.62%	202.38%
Accounts Receivable	-	0.01	0.1	-	-	-
Other Receivables	0.09	0.08	0.42	0.25	0.03	0.06
Receivables	0.09	0.09	0.51	0.25	0.03	0.06
Prepaid Expenses	2.83	0.39	0.29	0.11	0.08	0.07
Other Current Assets	0.88	0.25	0.94	0.5	0.59	0.36
Total Current Assets	20.37	22.8	19.01	12.52	23.15	17.42
Property, Plant & Equipment	-	-	-	0.2	0.3	0
Other Intangible Assets	0.4	0.41	0.46	0.52	0.43	0.47
Long-Term Accounts Receivable	-	-	0.01	-	-	-
Total Assets	20.77	23.21	19.49	13.24	23.88	17.9
Accounts Payable	0.04	0.03	0.03	3.32	2	0.35
Accrued Expenses	5.84	4.63	4.91	-	1.4	0.73
Current Portion of Leases	-	0.01	0.1	0.09	0.09	-
Other Current Liabilities	9.35	15.07	11.86	11.73	6.73	-
Total Current Liabilities	15.22	19.73	16.9	15.14	10.22	1.08
Long-Term Leases	-	-	0.01	0.11	0.2	-
Total Liabilities	15.22	19.73	16.91	15.25	10.41	1.08
Common Stock	107.89	103	81.19	58.93	57.41	42.4
Retained Earnings	-148.44	-146.76	-102.65	-78.15	-55.77	-35.05
Comprehensive Income & Other	46.09	47.24	24.03	17.21	11.82	9.46
Shareholders' Equity	5.54	3.48	2.58	-2.01	13.46	16.82
Total Liabilities & Equity	20.77	23.21	19.49	13.24	23.88	17.9
Total Debt	-	0.01	0.11	0.2	0.28	-
Net Cash (Debt)	16.56	22.06	17.16	11.46	22.17	16.93
Net Cash Growth	15.08%	28.55%	49.72%	-48.29%	30.95%	202.38%
Net Cash Per Share	0.22	0.30	0.25	0.19	0.42	0.43
Filing Date Shares Outstanding	82.19	80.93	70.99	69.93	59.13	46.23
Total Common Shares Outstanding	80.99	79.65	70.33	59.61	58.78	46.19
Working Capital	5.15	3.07	2.11	-2.62	12.93	16.34
Book Value Per Share	0.07	0.04	0.04	-0.03	0.23	0.36
Tangible Book Value	5.15	3.07	2.11	-2.53	13.03	16.35
Tangible Book Value Per Share	0.06	0.04	0.03	-0.04	0.22	0.35